[ET Net News Agency, 16 January 2023] HANSOH PHARMA (03692) rose 3.17% to HK$17.58.
It hits an intra-day high of HK$17.64, and an intra-day low of HK$16.9. The total shares
traded was 735,298, with a value of HK$12.75m. The active buy/sell ratio is 51:49, with
net buying turnover of HK$194,800. FUTU SEC INT'L accounts for greatest net responsive
buying turnover of HK$1.11m, with volume weighted average price of HK$17.358. GOLDMAN
SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$815,317, with
volume weighted average price of HK$17.347.
The Hang Seng Index now rose 185 points, or 0.85% to 21,924.
Basic Information
=================
----------------------------------
Nominal 17.580 % Chg +3.17%
High 17.640 Low 16.900
Shares Tr 735,298 Turnover 12.75m
10-D SMA 16.962 %H.V 47.998
20-D SMA 15.634 VWAP 17.339
50-D SMA 14.957 RSI14 67.714
----------------------------------
Status: Active buy/sell ratio is 51:49, with net buying turnover of HK$194,800
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
HANSOH PHARMA (03692) 17.58 +3.17
ALI HEALTH (00241) 7.49 -1.32
SINO BIOPHARM (01177) 4.92 -1.40
INNOVENT BIO (01801) 42.75 +1.42
JXR (01951) 7.95 +3.92
EVEREST MED-B (01952) 26.05 +9.22
WUXI BIO (02269) 74.50 +2.62
CANSINOBIO (06185) 77.60 +3.05
NH HEALTH-B (06606) 32.30 +6.60
AKESO-B (09926) 49.75 +2.16
---------------------------------------------
(ed)